Brief: Equasens H1 Revenue Up 9% To EUR 112.62 Mln
Aug 3 (Reuters) - Equasens SA EQSE.PA :
* H1 2023 REVENUE: UP 9% TO EUR 112.62M
* OUTLOOK: CONTINUING GROWTH IN H2 2023
* H1 PHARMAGEST DIVISION REPORTED SALES OF EUR 83.7M, UP 9%
FROM
H1 2022
Source text for Eikon: ID:nGNE8SfpBY
Further company coverage: EQSE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))
Recent news on Equasens SA
See all newsFrance's Equasens H1 profit up 10.5%, helped by acquisitions
French and Benelux stocks-Factors to watch Sept 23
Brief: Equasens Activates Business Continuity Plan After Fire In Its Subsidiary Asca In Chessy
France's Equasens H1 revenue rises on growth in maintenance and subscription businesses
Brief: Equasens H1 Revenue EUR 124.5 Mln